Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: Implications for the dietary management of elevated serum triglycerides

Journal of Clinical Lipidology

Volumn 3, Issue 4, 2009, Pages 281-288

  Velliquette, Rodney A ^a   Gillies, Peter J ^b   Kris Etherton, Penny M ^a   Green, John W ^b   Zhao, Guixiang ^a   Vanden Heuvel, John P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

Linolenic acid (ALA); (PPAR ); Eicosapentaenoic acid (EPA); Linoleic acid (LA); Metabolic syndrome; Peroxisome proliferation activator receptor ; Stearoyl CoA desaturase (SCD); Sterol response element binding protein 1c (SREBP 1c); Triglyceride (TG)

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACYL COENZYME A DESATURASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID ELONGASE 15; FATTY ACID ELONGASE 16; FATTY ACID SYNTHASE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MESSENGER RNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL STRAIN HEPG2; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; ENZYME ACTIVITY; ENZYME REGULATION; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 68449089088     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.06.002     Document Type: Article

References (35)

1. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000) 943-949
2. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
3. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel lll) final report. Circulation 106 (2002) 3142-3421
4. Adiels M., Olofsson S.O., Taskinen M.R., and Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28 (2008) 1225-1236
5. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40 (1999) 1549-1558
6. Nakamura M.T., and Nara T.Y. Structure, function and dietary regulation of Δ6, Δ5, and Δ9 desaturases. Annu Rev Nutr 24 (2004) 345-376
7. Man W.C., Miyazaki M., Chu K., and Ntambi J. Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J Lipid Res 47 (2006) 1928-1939
8. Miyazaki M., Kim Y.C., and Ntambi J.M. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res 42 (2001) 1018-1024
9. Miyazaki M., and Ntambi J.M. Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 68 (2003) 113-150
10. Atttie A.D., Flowers M.T., Flowers J.B., Groen A.K., Kuipers F., and Ntambi J.M. Stearoyl-CoA desaturase deficiency, hypercholesterolemia, cholestatsis, and diabetes. Nutr Rev 65 (2007) S35-S38
11. Yee J.K., Mao C.S., Hummel H.S., Lim S., Sugano S., Rehan V.K., Xiao G., and Lee W.N.P. Compartmentalization of stearoyl-CoA desaturase enzyme-1 activity in HepG2 cells. J Lipid Res 49 (2008) 2124-2134
12. Attie A.D., Krauss R.M., Gray-Keller M.P., Brownlie A., Miyazaki M., Kastelein J.J., Lusis A.J., Stalenhoef A.F.H., Stoehr J.P., Hayden M.R., and Ntambi J.M. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43 (2002) 1899-1907
13. Shiwaku K., Hashimoto M., Kitajima K., Nogi A., Anuurad E., Enkhmaa B., Kim J.M., Kim I.S., Lee S.K., Oyunsuren T., Shido O., and Yamane Y. Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians. J Lipid Res 45 (2004) 914-922
14. Mar-Heyming R., Miyazaki M., Weissglass-Volkov D., Kolaitis N.A., Sadaat N., Plaisier C., Pajukanta P., Cantor R.M., de Bruin T.W.A., Ntambi J.M., and Lusis A.J. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Arterioscler Thrombo Vasc Biol 28 (2008) 1193-1199
15. Enoch H.G., Catala A., and Strittmatter P. Mechanism of rat liver microsomal stearoyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions and the function of lipid. J Biol Chem 251 (1976) 5095-5103
16. Miyazaki M., Bruggink S.M., and Ntambi J.M. Identification of mouse palmitoyl-coenzyme A Δ9-desaturase. J Lipid Res 47 (2006) 700-704
17. Petersson H., Basu S., Cederholm T., and Riserus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analysis in middle-aged men. Br J Nutr 99 (2008) 1186-1189
18. Petersson H., Lind L., Hulthe J., Elmgren A., Cederholm T., and Riserus U. Relationship between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 203 (2009) 298-303
19. Corpeleijn E., Feskens E.J.M., Jansen E.H.J.M., Mensink M., Saris W.H.M., de Bruin T.W.A., and Blaak E.E. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profiles and desaturase activities: the SLIM study. Diabetologia 49 (2006) 2392-2401
20. Warensjo E., Riserus U., and Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48 (2005) 1999-2005
21. Paillard F., Catheline D., Le Duff F., Bouriel M., Deugnier Y., Pouchard M., Daubert J.C., and Legrand P. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 18 (2008) 436-440
22. Dobrzyn A., and Ntambi J.M. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 6 (2005) 169-174
23. Jiang G., Li Z., Liu F., Ellsworth K., Dallas-Yang Q., Wu M., Ronan J., Esau C., Murphy C., Szalkowski D., Bergeron R., Doebber T., and Zhang B.B. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115 (2005) 1030-1038
24. Warensjo E., Riserus U., Gustafsson I.B., Mohsen R., Cederholm T., and Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr Metab Cardiovasc Dis 18 (2008) 683-690
25. Griel A.E., Cao Y., Bagshaw D.D., Cifelli A.M., Holub B., and Kris-Etherton P.M. A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr 138 (2008) 761-767
26. Zhao G., Etherton T.D., Martin K.R., West S.G., Gillies P.J., and Kris-Etherton P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134 (2004) 2991-2997
27. Zhao G., Etherton T.D., Martin K.R., Gillies P.J., West S.G., and Kris-Etherton P.M. Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesteroloemic subjects. Am J Clin Nutr 85 (2007) 385-391
28. Brenna J.T., Salem Jr. N., Sinclair A.J., and Cunnane S.C. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80 (2009) 85-91
29. Sampath H., and Ntambi J.M. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-α: independent and interactive roles in the regulation of lipid metabolism. Curr Opin Clin Nutr Metab Care 9 (2006) 84-88
30. Matsuzaka T., Shimano H., Yahagi N., Kato T., Atsumi A., Yamamoto T., Inoue N., Ishikawa M., Okada S., Ishigaki N., Iwasaki H., Iwasaki Y., Karasawa T., Kumadaki S., Matsui T., Sekiya M., Ohashi K., Hasty A.H., Nakagawa Y., Takahashi A., Suzuki H., Yatoh S., Sone H., Toyoshima H., Osuga J., and Yamada N. Crucial role of a long-chain fatty acid elongase, Elov16, in obesity-induced insulin resistance. Nat Med 13 (2007) 1193-1202
31. Harris W.S., and von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
32. Warensjo E., Sundstroom J., Vessby B., Cederholm T., and Riserus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 88 (2008) 203-209
33. Saito Y., Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., Shirato K., for the JELIS Investigators, and Japan. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 200 (2008) 135-140
34. Harris W.S., Mozaffarian D., Lefevre M., Toner C.D., Colombo J., Cunnane S.C., Holden J.M., Klurfeld D.M., Morris M.C., and Whelan J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139 (2009) 804S-819S
35. Collins N., Tighe A.P., Brunton S.A., and Kris-Etherton P.M.K. Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective. J Am Coll Nutr 27 (2008) 659-666